retatrutide phase 2 trial obesity nejm 2023 VisualAbstract: reduces body weight by 17.5% in patients with retatrutide phase 2 nejm 2023

This enables a semi-permanent, just-eaten sensation of fullness that consequently leads to decreased food intake and, ultimately, weight loss

Worth noting: Lemme GLP-1 was involved in a recent class action lawsuit for false advertising

Overall, Retatrutide provides a versatile experimental platform for studying integrated endocrine signaling across metabolic tissues

People using GLP-1a weight loss and diabetes medications, such as Ozempic and Mounjaro, experience a dramatic slowdown in their intestinal transit time - down to just a fifth of the usual rate

Compounded versions of semaglutide (the drug found in Wegovy) and tirzepatide (the drug in Zepbound), on the other hand, often come at lower prices and are much easier to get